Reactions of the melatonin metabolite N1-acetyl-5- methoxykynuramine (AMK) with the ABTS cation radical: Identification of new oxidation products

Redox Report

Volumn 11, Issue 1, 2006, Pages 15-24

  Than, Ni Ni ^a   Heer, Christina ^a   Laatsch, Hartmut ^a   Hardeland, Rüdiger ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

ABTS cation radical; AMK; Kynuramines; Melatonin

Indexed keywords

AROMATIC AMINE; AROMATIC AMINO ACID; DIMER; KYNURAMINE; MELATONIN; N 1 ACETYL 5 METHOXYKYNURAMINE; NITROGEN; OLIGOMER; SCAVENGER; SULFONIC ACID DERIVATIVE; TETRAMER; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG STRUCTURE; HORMONE METABOLISM; IN VIVO STUDY; INFRARED SPECTROSCOPY; ISOMER; ISOTOPE LABELING; MASS SPECTROMETRY; METABOLITE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; SEPARATION TECHNIQUE;

ANTIOXIDANTS; BENZOTHIAZOLES; CATIONS; DIMERIZATION; FREE RADICAL SCAVENGERS; FREE RADICALS; KYNURAMINE; MAGNETIC RESONANCE SPECTROSCOPY; MELATONIN; MOLECULAR STRUCTURE; NITRO COMPOUNDS; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; SULFONIC ACIDS;

EID: 33745190395     PISSN: 13510002     EISSN: 13510002     Source Type: Journal    
DOI: 10.1179/135100006X100977     Document Type: Article

References (37)

1. Hardeland R. Melatonin: multiple functions in signaling and protection. In: Altmeyer P, Hoffmann K, Stücker M. (eds) Skin Cancer and UV Radiation. Berlin: Springer, 1997; 186-198.
2. Tan D-X, Manchester LC, Reiter RJ et al. High physiological levels of melatonin in the bile of mammals. Life Sci 1999; 65: 2523-2529.
3. Tan D-X, Manchester LC, Hardeland R et al. Melatonin - a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34: 75-78.
4. Hardeland R, Poeggeler B. Non-vertebrate melatonin. J Pineal Res 2003; 34: 233-241.
5. Hardeland R. Antioxidative protection by melatonin - Multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27: 119-130.
6. Hardeland R, Reiter RJ, Poeggeler B, Tan D-X. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993; 17: 347-357.
7. Tan D-X, Chen L-D, Poeggeler B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
8. Reiter RJ. Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 1998; 56: 359-384.
9. Reiter RJ, Tan D-X, Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 2002; 123: 1007-1019.
10. Reiter RJ, Tan D-X, Mayo JC et al. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003; 50: 1129-1146.
11. 1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Report 2003; 8: 205-213.
12. Hardeland R, Ressmeyer A-R, Zelosko V et al. Metabolites of melatonin: formation and properties of the methoxylated kynuramines AFMK and AMK. In: Haldar C, Singh SS. (eds) Recent Advances in Endocrinology and Reproduction: Evolutionary, Biotechnological and Clinical Applications. Varanasi: Banaras Hindu University, 2004; 21-38.
13. 1-acetyl-5-methoxykynuramine, by activated leukocytes. J Pineal Res 2004; 37: 171-175.
14. Hardeland R, Coto-Montes A, Poeggeler B. Circadian rhythms, oxidative stress and antioxidative defense mechanisms. Chronobiol Int 2003; 20: 921-962.
15. Acuna-Castroviejo D, Escames G, Leon J et al. Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol 2003; 527: 549-557.
16. Srinivasan V, Pandi-Perumal SR, Maestroni GJM et al. Role of melatonin in neurodegenerative diseases. Neurotox Res 2005; 7: 293-318.
17. 2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 2294-2296.
18. Re R, Pellegrini N, Proteggente A et al. Antioxidant activity applying an improved ABTS cation radical decolorization assay. Free Radic Biol Med 1999; 26: 1231-1237.
19. Tan D-X, Hardeland R, Manchester LC et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 2003; 34: 249-259.
20. Kennaway DJ, Hugel HM, Clarke S et al. Structure-activity studies of melatonin analogues in prepubertal male rats. Aust J Biol Sci 1988; 41: 393-400.
21. Bamberger E, Lagutt J. Ueber das Verhalten des Phenylhydroxylamins gegen alkoholische Schwefelsäure und gegen Anilin. Chem Ber 1898; 31: 1500-1508.
22. Shaabani A, Lee DG. Solvent free permanganate oxidations. Tetrahedron Lett 2001; 34: 5833-5836.
23. Corma A, Garcia H., Iborra S et al. Cooperative effect of acid sites in the photocyclization of azobenzene within the zeolite microenvironment. J Am Chem Soc 1993; 115: 2177-2180.
24. Tung C-H, Guan J-Q. Modification of photochemical reactivity by Nafion, photocyclization and photochemical cis-trans isomerization of azobenzene. J Org Chem 1996; 61: 9417-9421.
25. Aekermark B, Oslob JD, Heuschert U. Catalytic oxidative aromatic cyclizations with palladium. Tetrahedron Lett 1995; 36: 1325-1326.
26. Razus AC, Birzan L, Nae S et al. 1,1′-Biazulene derivatives. Synthesis and reactions. ARKIVOC 2002; 142-153. [Chem. Abstr. 138:303954.]
27. Tan D-X, Manchester LC, Reiter RJ et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta 1999; 1472: 206-214.
28. Hardeland R, Fuhrberg B. Ubiquitous melatonin - Presence and effects in unicells, plants and animals. Trends Comp Biochem Physiol 1996; 2: 25-45.
29. Hardeland R. Melatonin and 5-methoxytryptamine in non-metazoans. Reprod Nutr Dev 1999; 39: 399-408.
30. Kelly RW, Amato F, Seamark RF. N-Acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. Biochem Biophys Res Commun 1994; 121: 372-379.
31. 1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005; 165: 139-149.
32. Entrena A, Camacho ME, Carrion MD et al. Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem 2005; 48: 8174-8181.
33. Hirata F, Hayaishi O, Tokuyama T, Senoh S. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 1974; 249: 1311-1313.
34. Tricoire H, Locatelli A, Chemineau P et al. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 2002; 143: 84-90.
35. Messner M, Hardeland R, Rodenbeck A, Huether G. Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 1998; 25: 251-259.
36. Messner M, Hardeland R, Rodenbeck A, Huether G. Effects of continuous melatonin infusions on steady-state plasma melatonin levels, metabolic fate and tissue retention in rats under near physiological conditions. Adv Exp Med Biol 1999; 467: 303-313.
37. Hardeland R, Poeggeler B. Chemistry and biology of melatonin oxidation. In: Haldar C, Singaravel M, Maitra SK. (eds) Treatise on Pineal Gland and Melatonin. Enfield: Science Publishers (USA), 2002; 407-422.